Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by stanleyon May 15, 2012 9:38am
348 Views
Post# 19909513

RE: News Release - Brigus

RE: News Release - Brigus

Kwel2:

My apologies,not exactly the NR but the pre-cursor to the NR.. to my Stockwatch Canada account. See SEDAR postings of May 14th. The actual NR came out this AM at 8:10 AM.

Recent Bulletins

Date ET Symbol Price Type Headline
2012-05-15 08:10 BRD 0.77 News Release Brigus Gold earns $5.52-million (U.S.) in Q1
2012-05-14 17:37 BRD 0.79 SEDAR Interim Financial Statements SEDAR Interim Financial Statements
2012-05-14 17:37 BRD 0.79 SEDAR MD & A SEDAR MD & A
2012-05-07 08:16 BRD 0.87 News Release Brigus Gold to sell Calais notes for $6-million (U.S.)
2012-05-03 08:13 BRD 0.85 News Release Brigus Gold produces 7,088 oz Au at 3.66 g/t in April
2012-04-24 07:45 BRD 0.80 Shareholders Letter Brigus to produce 25,000 oz Au quarterly by year-end
2012-04-23 16:07 BRD 0.80 News Release Brigus Gold to release Q1 results May 15

Cheers

Stanley

Bullboard Posts